A carregar...
A human-on-a-chip approach to tackling rare diseases
Drug development for rare diseases, classified as diseases with a prevalence of <200 000 patients, is limited by high cost of research and low target population. Owing to a lack of representative disease models, research has been challenging for orphan drugs. Human-on-a-chip (HoaC) technology, wh...
Na minha lista:
| Publicado no: | Drug Discov Today |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856435/ https://ncbi.nlm.nih.gov/pubmed/31412288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2019.08.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|